Graftys Granted U.S. Patent for Highly-osteogenic Biomaterial

Graftys has been granted U.S. Patent No. 13/923,577 covering GRFT-R02, a highly-osteogenic biomaterial for bone tissue regeneration (e.g., acetabular reconstruction, posterolateral spinal fusion, non-union and complex fracture healing with poor vascularization).

The covered material is the result of collaboration between Graftys and the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us